Empowering Global Expansion: Stellar Biotech Attends Boao Innovation Forum & Forges Major Strategic Partnership

Created on Today

On July 13, the **First Innovative Forum on Advanced Clinical Therapies for Liver Diseases** was successfully held in Boao, Hainan. The event was hosted by Hainan Boao Super Hospital, Hainan Cancer Hospital, and Hainan Lecheng Institute of Real-World Research, and organized by four well-known enterprises including Shanghai Sailiwei Biotechnology Co., Ltd.

**Stellar Biotech** was invited to attend the forum, focusing on cutting-edge technologies and promoting advanced domestic clinical liver disease therapies to go global for the benefit of patients worldwide.

At the international cooperation signing ceremony during the forum, **MJ BIO PTE. LTD**, an affiliate of Stellar Biotech, signed a strategic cooperation agreement as a partner with Boao Super Hospital and Shanghai Huicun Medical Technology Co., Ltd., the parent company of Shanghai Sailiwei Biotechnology Co., Ltd.

Stellar Biotech was highly recognized by its partners and other participating institutions for its market advantages in providing one-stop services in Southeast Asia.

Following this strategic cooperation, the three parties will integrate their respective strengths to advance domestic and international collaboration on advanced liver disease therapies, and deliver high-quality medical and health services to patients at home and abroad.

As for Boao Super Hospital: it is a state-controlled general hospital that gathers a team of top academicians and experts nationwide, and benefits from the favorable "National Nine Policies".

Leveraging the special medical device and drug policies, the hospital has introduced a number of licensed medical and pharmaceutical projects, achieving many "first cases in China".

In addition, Boao Super Hospital conducts real-world research, making important contributions to the introduction of advanced foreign medical technologies and licensed drugs and devices into the Chinese market.